BEONE MEDICINES LTD. Pre-Tax Income
BEONE MEDICINES LTD. (ONC) reported Pre-Tax Income of $312.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest · last filed 2026-08-05
- BEONE MEDICINES LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-06-30 was $312.46M, a 213.87% increase year-over-year.
- BEONE MEDICINES LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2026-03-31 was $259.21M, a 1140.26% increase year-over-year.
- BEONE MEDICINES LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-12-31 was $149.24M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for the quarter ending 2025-09-30 was $147.16M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2025 was $416.85M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2024 was -$533.00M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2023 was -$825.84M.
- BEONE MEDICINES LTD. income (loss) from continuing operations before income taxes, noncontrolling interest for fiscal 2022 was -$1.96B.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $312.46M 10-Q · filed 2026-08-05 | $571.67M 10-Q · filed 2026-08-05 | $720.91M derived: sum of 3 quarters · filed 2026-08-05 | $868.08M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $259.21M 10-Q · filed 2026-05-06 | $408.46M derived: sum of 2 quarters · filed 2026-05-06 | $555.62M derived: sum of 3 quarters · filed 2026-05-06 | $655.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $149.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $296.40M derived: sum of 2 quarters · filed 2026-02-26 | $395.95M derived: sum of 3 quarters · filed 2026-08-05 | $416.85M 10-K · filed 2026-02-26 |
| 2025-09-30 | $147.16M 10-Q · filed 2025-11-06 | $246.71M derived: sum of 2 quarters · filed 2026-08-05 | $267.61M 10-Q · filed 2025-11-06 | $182.26M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $99.55M 10-Q · filed 2026-08-05 | $120.45M 10-Q · filed 2026-08-05 | $35.10M derived: sum of 3 quarters · filed 2026-08-05 | -$63.21M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $20.90M 10-Q · filed 2026-05-06 | -$64.45M derived: sum of 2 quarters · filed 2026-05-06 | -$162.75M derived: sum of 3 quarters · filed 2026-05-06 | -$268.68M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$85.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$183.66M derived: sum of 2 quarters · filed 2026-02-26 | -$289.57M derived: sum of 3 quarters · filed 2026-02-26 | -$533.00M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$98.30M 10-Q · filed 2025-11-06 | -$204.22M derived: sum of 2 quarters · filed 2025-11-06 | -$447.65M 10-Q · filed 2025-11-06 | -$798.42M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$105.92M 10-Q · filed 2025-08-06 | -$349.35M 10-Q · filed 2025-08-06 | -$700.12M derived: sum of 3 quarters · filed 2026-02-26 | -$470.78M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$243.43M 10-Q · filed 2025-05-07 | -$594.20M derived: sum of 2 quarters · filed 2026-02-26 | -$364.86M derived: sum of 3 quarters · filed 2026-02-26 | -$732.32M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$350.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$121.43M derived: sum of 2 quarters · filed 2026-02-26 | -$488.90M derived: sum of 3 quarters · filed 2026-02-26 | -$825.84M 10-K · filed 2026-02-26 |
| 2023-09-30 | $229.34M 10-Q · filed 2024-11-12 | -$138.13M derived: sum of 2 quarters · filed 2024-11-12 | -$475.06M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | -$367.46M 10-Q · filed 2024-08-07 | -$704.40M 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | -$336.94M 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | -$1.96B 10-K · filed 2025-02-27 | |||
| 2017-09-30 | $114.22M 10-Q · filed 2017-11-13 | $53.74M derived: sum of 2 quarters · filed 2017-11-13 | $3.30M 10-Q · filed 2017-11-13 | -$34.55M derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | -$60.48M 10-Q · filed 2017-08-09 | -$110.92M 10-Q · filed 2017-08-09 | -$148.77M derived: sum of 3 quarters · filed 2017-08-09 | -$184.14M derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-03-31 | -$50.44M 10-Q · filed 2017-05-10 | -$88.29M derived: sum of 2 quarters · filed 2017-05-10 | -$123.66M derived: sum of 3 quarters · filed 2017-11-13 | -$147.65M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-12-31 | -$37.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-22 | -$73.22M derived: sum of 2 quarters · filed 2017-11-13 | -$97.21M derived: sum of 3 quarters · filed 2017-11-13 | -$119.16M 10-K · filed 2017-03-22 |
| 2016-09-30 | -$35.37M 10-Q · filed 2017-11-13 | -$59.36M derived: sum of 2 quarters · filed 2017-11-13 | -$81.31M 10-Q · filed 2017-11-13 | |
| 2016-06-30 | -$23.99M 10-Q · filed 2017-08-09 | -$45.95M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | -$21.96M 10-Q · filed 2017-05-10 | |||
| 2015-12-31 | -$57.10M 10-K · filed 2017-03-22 | |||
| 2014-12-31 | -$18.55M 10-K · filed 2017-03-22 |